NAD+: dinucleótido de nicotinamida y adenina

What Is Naltrexone (Especially Low-Dose)?

Naltrexone is an opioid receptor antagonist — it blocks mu-opioid receptors in the brain and body. At full dose, it completely shuts down opioid effects (used for addiction treatment). At low dose (LDN), it temporarily blocks receptors for a few hours → triggers a rebound increase in endorphins and enkephalins → modulates the immune system and reward pathways without causing dependence or major side effects.

 

How Does Naltrexone Work?

• For Weight Loss & Appetite Control: Blocks mu-opioid receptors in the brain’s reward centers → reduces the “pleasure hit” from palatable/high-carb/sugary foods → lowers hedonic hunger and cravings. The rebound endorphin increase helps regulate appetite signals and may improve insulin sensitivity indirectly.

• For Autoimmune Inflammation & Pain: Temporary opioid receptor blockade (a few hours) upregulates endorphin production and modulates immune cells (especially T-regulatory cells and glial cells). This shifts the immune system toward anti-inflammatory pathways, reduces pro-inflammatory cytokines (TNF-α, IL-6), and calms overactive microglia in the central nervous system → helps lower chronic pain, fatigue, and flare frequency in many autoimmune/inflammatory conditions.

In simple terms: At low dose, naltrexone briefly “tricks” the body into making more of its own feel-good chemicals and dialing down immune overdrive — helping with both reward-driven eating and runaway inflammation/pain.

​​​

Potential Benefits

 Weight Loss & Craving Control

• Reduces cravings for sweets, carbs, and comfort foods

• Lessens emotional/stress eating and “food addiction” patterns

• May support 5–10% body weight reduction over 6–12 months (stronger when combined with bupropion, diet, and exercise — as in Contrave studies)

• Helps with leptin resistance and hedonic hunger without stimulant side effects

Autoimmune, Inflammatory & Pain Support

• Reduced flare frequency and severity in conditions like Hashimoto’s, rheumatoid arthritis, fibromyalgia, Crohn’s, MS, or complex regional pain syndrome (based on observational reports)

• Lowered chronic pain (especially central/nerve-related or fibromyalgia-type)

• Improved fatigue, brain fog, and overall quality of life in inflammatory states

• Calms glial cell activation → helps with neuroinflammation and “sickness behavior”

Many people report subtle but meaningful changes — fewer cravings and more control around food, plus a noticeable drop in daily pain/inflammation — after 4–12 weeks of consistent low-dose use.